Who needs bleomycin in classic Hodgkin lymphoma? Comment on: “Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVD”

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-09-24
DOI
https://doi.org/10.3324/haematol.2026.301946
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Who needs bleomycin in classic Hodgkin lymphoma? Comment on: “Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVD”

Annamaria Vincenzi, Picardi Marco
Haematologica
Lymphoma Diagnosis and Treatment
article

Who needs bleomycin in classic Hodgkin lymphoma? Comment on: “Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVD”

Annamaria Vincenzi, Picardi Marco
article en

Abstract

No abstract available for this paper.
Haematologica
Federico II University Hospital (IT)
Zero hunger
Openalex Percentile: Top 11%
Lymphoma Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Who needs bleomycin in classic Hodgkin lymphoma? Comment on: “Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVD” — Annamaria Vincenzi, Picardi Marco · Haematologica (2026) | TGRS Research Map | TGRS